The article you requested is

ASCP Corner: Lessons Learned From <span style="font-variant:small-caps;">d</span>-Cycloserine: The Promise and Limits of Drug Facilitation of Exposure Therapy

J Clin Psychiatry 2013;74(4):415-416

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

We, like many other psychiatrists, psychologists, and drug developers, look forward to a day when medication and psychotherapy are typically combined in a rational manner. At present, most such combinations in the field are at best accidental and represent incremental improvements, whereas at worst the 2 methods may clash. Set against this backdrop, recent and replicated findings that the medication d-cycloserine (DCS) can enhance psychotherapy are of particular interest, because DCS was applied to a psychotherapeutic intervention on the basis of basic research.